IL6 and obesity disorder: ELISA findings revealed that the levels of interleukin‐6 receptor subunit beta (gp130), oncostatin‐M (OSM), and IL‐6 in serum and hippocampus decreased in obesity, whereas they increased in AD, aligning with the results of the MR Analysis.